SYNPLOGEN - Trademark Details
Status: 700 - Registered
Serial Number
79272215
Registration Number
6115549
Word Mark
SYNPLOGEN
Status
700 - Registered
Status Date
2020-08-04
Filing Date
2019-08-22
Registration Number
6115549
Registration Date
2020-08-04
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2020-05-19
Attorney Name
Law Office Assigned Location Code
N50
Employee Name
VO, JULIE
Statements
Goods and Services
Research and development relating to DNA synthesis technology; technical advisory services and information technology consulting services relating to DNA synthesis technology; research and development in the fields of bacteriology, cytology, antibody technology, chemistry, immunology, and gene expression systems; scientific research in the fields of genetics and genetic engineering; DNA screening for scientific research purposes; research and development, quality control for others, and technical advisory services relating thereto in the fields of protein, antibody, microorganisms, and cells; structural and functional analysis of the genome with genome synthesis technology; DNA screening for scientific research purposes with genome synthesis technology; research and development relating to genome synthesis technology; technical advisory services and information technology consulting services relating to genome synthesis technology; research and development, quality control for others, and technical advisory services relating thereto in the fields of protein, antibody, microorganisms, and cells, all with genome synthesis technology; research and development in the fields of bacteriology, cytology, antibody technology, chemistry, immunology, and gene expression systems, all with genome synthesis technology; scientific research in the fields of genetics and genetic engineering with genome synthesis technology; testing, inspection and research of pharmaceuticals, cosmetics or foodstuffs, all with genome synthesis technology; development of pharmaceuticals, cosmetics or foodstuffs, all with genome synthesis technology; technical advisory services relating to development of pharmaceuticals, cosmetics or foodstuffs, all with genome synthesis technology; information technology services relating to development of pharmaceuticals, cosmetics or foodstuffs, all with genome synthesis technology; testing, inspection and research relating to medical treatment or medical technology with genome synthesis technology; information technology consulting services for testing, inspection or research relating to medical treatment or medical technology with genome synthesis technology; testing and research relating to genome or gene to which genome synthesis technology is applied; research and development for the pharmaceutical industry and biotechnology industry with genome synthesis technology; research and development relating to biotechnology for others; research and development relating to genome synthesis technology for others; biotechnology research; research and development in the fields of genomics and biotechnology; technical advisory services in the fields of genomics and biotechnology; structural and functional analysis of genomes; testing, inspection or research on agriculture, livestock breeding or fisheries; development of pharmaceutical preparations and medicines; product development for others; research and development of new products for others; development of new technology for others in the fields of genomics and biotechnology; research and development of genome synthesis technology for others; research and development of new products for others with DNA synthesis technology; DNA synthesis services for others for scientific research purposes; research and development services in the field of gene expression systems; research and development services in the fields of microorganisms and cells; DNA sequence design services for scientific research purposes; research and development of microorganisms for others; research and development of microorganisms which produce useful substances for others; technical research in the field of microorganisms; bacteriological research; biological research
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-11-22
Primary Code
042
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Rebeccah Gan
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1498799
International Registration Date
2019-08-22
International Publication Date
2019-11-21
International Renewal Date
2029-08-22
Auto Protection Date
2021-05-21
International Status
001 - Request for extension of protection established
International Status Date
2019-11-21
Priority Claimed In
True
Priority Claimed Date
2019-04-11
First Refusal In
True
Trademark Events
Event Date | Event Description |
2019-11-21 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
2019-11-22 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2019-11-22 | ASSIGNED TO EXAMINER |
2019-11-26 | APPLICATION FILING RECEIPT MAILED |
2019-12-03 | NON-FINAL ACTION WRITTEN |
2019-12-04 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
2020-01-02 | REFUSAL PROCESSED BY MPU |
2020-01-02 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
2020-01-14 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2020-01-14 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2020-01-14 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2020-01-17 | REFUSAL PROCESSED BY IB |
2020-01-31 | NON-FINAL ACTION WRITTEN |
2020-01-31 | NON-FINAL ACTION E-MAILED |
2020-01-31 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2020-03-12 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2020-03-19 | ASSIGNED TO LIE |
2020-03-23 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2020-03-23 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2020-04-13 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2020-04-29 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2020-05-19 | PUBLISHED FOR OPPOSITION |
2020-05-19 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2020-08-04 | REGISTERED-PRINCIPAL REGISTER |
2020-11-04 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
2020-11-25 | FINAL DISPOSITION PROCESSED |
2020-11-25 | FINAL DISPOSITION NOTICE SENT TO IB |
2020-12-12 | FINAL DECISION TRANSACTION PROCESSED BY IB |
2022-02-05 | LIMITATION OF GOODS RECEIVED FROM IB |